Suchergebnisse - "Matrajt, Laura"

PubPharm (62)

31

Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease

enthalten in: Emerging infectious diseases | 2020

von Matrajt, L. | Leung, T.

32

Reply to Lindsey, Höschler, and de Silva

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Matrajt, L. | Halloran, M. | Antia, R.

CommentOn: Clin Infect Dis. 2020 Mar 3;70(6):1029-1037. - PMID 31056675

33

Successes and Failures of the Live-attenuated Influenza Vaccine : Can We Do Better?

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Matrajt, L. | Halloran, M. | Antia, R.

CommentIn: Clin Infect Dis. 2020 May 6;70(10):2236-2237. - PMID 31412101

34

Vaccine optimization for COVID-19 : Who to vaccinate first?

enthalten in: Science advances | 2020

von Matrajt, L. | Eaton, J. | Leung, T. | +1

UpdateOf: medRxiv. 2020 Dec 15;:. - PMID 32817963

35

Successes and failures of the live-attenuated influenza vaccine, can we do better?

enthalten in: bioRxiv.org | 2020

von Matrajt, L. | Halloran, M. | Antia, R.

36

Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children

enthalten in: Scientific reports | 2017

von Matrajt, L. | Gantt, S. | Mayer, B. | +6

37

Dynamics of Persistent Oral Cytomegalovirus Shedding During Primary Infection in Ugandan Infants

enthalten in: The Journal of infectious diseases | 2016

von Mayer, B. | Matrajt, L. | Casper, C. | +5

38

Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies

enthalten in: Vaccine | 2016

von Feldstein, L. | Matrajt, L. | Elizabeth Halloran, M. | +3

39

Dynamics of Persistent Oral Cytomegalovirus Shedding During Primary Infection in Ugandan Infants

Erschienen: 2016

von Mayer, B. | Matrajt, L. | Casper, C. | +5

40

Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies

enthalten in: Vaccine | 2016

von Feldstein, L. | Matrajt, L. | Elizabeth Halloran, M. | +2